Diagnosing Dementia or Alzheimer's in Down Syndrome
Begin screening for Alzheimer's disease at age 40 years in all adults with Down syndrome using a structured, stepwise diagnostic approach that establishes baseline functioning and tracks decline over time with validated cognitive assessment tools specific to intellectual disabilities 1, 2.
Why Screen at Age 40
By age 40, all adults with Down syndrome exhibit neuropathologic changes consistent with Alzheimer's disease on autopsy, though clinical dementia is not inevitable 1. At least 50% of those aged 60+ will develop clinical dementia 1. The triplication of chromosome 21 causes overexpression of amyloid precursor protein, making Down syndrome the only genetically inherited intellectual disability indisputably linked to early-onset Alzheimer's disease 1. This represents a strong recommendation from the Global Down Syndrome Foundation guidelines 2.
Structured Diagnostic Algorithm
Step 1: Establish Baseline Functioning First
The cornerstone of diagnosis is documenting change from baseline 1. Without knowing the individual's premorbid cognitive and functional abilities, you cannot diagnose dementia. Obtain detailed information from long-term caregivers or family members about:
- Previous cognitive abilities
- Daily living skills
- Social functioning
- Behavioral patterns
- Personality characteristics
This baseline is highly individualized in intellectual disabilities and must be established before any decline can be identified 1.
Step 2: Comprehensive Medical History
Focus specifically on conditions that accelerate dementia risk 1:
- Cardiovascular disease
- Cerebrovascular disease or stroke
- Head injury or concussion history
- Sleep disorders (often poorly treated)
- Thyroid disease
- Vitamin B12 deficiency
- Metabolic syndrome components (obesity, diabetes, hypertension)
Step 3: Rule Out Reversible Causes
Common pitfall: Attributing cognitive changes to dementia when treatable conditions are responsible 1. Screen for:
- Sensory deficits (hearing loss, vision changes)
- Metabolic disturbances (electrolyte abnormalities, glucose dysregulation, B12/folate deficiencies, thyroid dysfunction, anemia)
- Medication toxicity (antiepileptic drugs, psychoactive medications)
- Depression and psychiatric illness (which presents atypically in intellectual disabilities)
Step 4: Assess for Psychiatric Comorbidities
Beware diagnostic overshadowing—the tendency to attribute symptoms to intellectual disability rather than recognizing emerging psychiatric illness 1. In Down syndrome with dementia, prefrontal symptoms are common 1:
- Apathy and indifference
- Uncooperativeness
- Social withdrawal
- Impaired adaptive functioning
- Neurovegetative signs (appetite changes, weight loss, sleep disturbances)
Depression may be an early manifestation rather than a differential diagnosis 1.
Step 5: Use Validated Cognitive Assessment Tools
Standard tools like the Folstein Mini-Mental State Examination are inappropriate for this population 1. Use instruments specifically validated for intellectual disabilities 1, 3:
- Dementia Scale for Down's Syndrome
- Cambridge Examination for Mental Disorders of Older People with Down's Syndrome (CAMDEX-DS) - has established diagnostic thresholds with high accuracy (AUC 0.998 for dementia, 0.954 for prodromal Alzheimer's) 3
- Dementia Questionnaire for People With Learning Disabilities
- Down's Syndrome Mental State Examination
- Test for Severe Impairment
The CAMDEX-DS informant interview is particularly valuable, with Section B (memory and orientation) accurately diagnosing dementia even when psychiatric comorbidities are present 3. The key is tracking scores over time to document decline, not comparing to population norms 1.
Step 6: Consider Biomarker Testing
Recent advances support using biomarkers in Down syndrome 4, 5:
- Plasma assays for amyloid and tau proteins show high diagnostic accuracy (up to 99-100% in some studies) 5
- PET imaging for amyloid and tau deposition 4, 6
- 18F-FDG PET to identify neurodegenerative patterns, though interpretation requires expertise given pre-existing brain differences 6
- MRI for cortical thickness measurements correlating with CAMDEX-DS scores 3
These tools are increasingly available and can differentiate dementia from baseline intellectual disability 4.
Step 7: Recognize Early Behavioral Markers
Behavioral symptoms may precede obvious cognitive decline 7. Early indicators include:
- Agitation and aggression
- Hallucinations
- Apathy
- Executive function decline
- Language deterioration
- Attention deficits
These behavioral changes can serve as early diagnostic markers and should prompt formal assessment 7.
Step 8: Assess Safety and Support Needs
Evaluate current living conditions and support adequacy, as needs will escalate with dementia progression 1. Think proactively about future care requirements even if current supports seem adequate 1.
Key Clinical Pitfalls to Avoid
Waiting for obvious memory loss: In Down syndrome, executive dysfunction, behavioral changes, and social withdrawal may appear before memory deficits 1, 7
Using general population screening tools: These lack validity in intellectual disabilities and will give misleading results 1
Failing to establish baseline: Without documented premorbid functioning, you cannot diagnose dementia 1
Diagnostic overshadowing: Attributing new symptoms to intellectual disability rather than recognizing emerging dementia or psychiatric illness 1
Missing treatable causes: Always rule out reversible metabolic, sensory, and psychiatric contributors before diagnosing dementia 1
Synthesizing the Diagnosis
Dementia diagnosis requires documented decline from baseline in multiple cognitive domains affecting daily functioning 1. By systematically gathering information through these steps, you build evidence for or against dementia. The diagnosis should be clear by the end of this structured evaluation 1.
Adults with Down syndrome should be included in memory clinic assessments and offered the same dementia treatments available to the general population 4. The Swedish dementia registry (SveDem) now includes Alzheimer's disease due to genetic overload in Down syndrome as a specific diagnostic category, providing a model for systematic tracking 4.